Sox4 Expression in Melanoma: A Novel Prognostic Marker and Therapeutic Target

Research investigators published a study in The American Journal of Pathology, concluding that Sox4 expression has significant prognostic implications in human cutaneous melanoma. The study evaluated Sox4 expression in 180 melanocytic lesions, revealing a remarkable reduction in metastatic melanoma compared to dysplastic nevi. This reduction in Sox4 expression was found to be correlated with enhanced cell migration and invasion in melanoma cells. The researchers suggested that Sox4 may serve as a potential therapeutic target for human melanoma.

Key Takeaways:

• Sox4 expression is significantly reduced in metastatic melanoma compared to dysplastic nevi, with a p-value of 0.003.
• This reduction in Sox4 expression is correlated with enhanced cell migration and invasion in melanoma cells.
• Sox4 regulates melanoma cell migration and invasion in an NF-?B p50-dependent manner.
• Sox4 may serve as a prognostic marker and potential therapeutic target for human melanoma.
• The study evaluated Sox4 expression in 180 melanocytic lesions, providing a comprehensive dataset for melanoma research.
• S.M. Jafarnejad and colleagues published their study, contributing significant insights to the field of melanoma research.

Statistics:

• 180 melanocytic lesions were evaluated for Sox4 expression.
• Sox4 expression was reduced by 3% in metastatic melanoma compared to dysplastic nevi (p-value = 0.003).
• Melanoma cell migration and invasion were significantly enhanced in the absence of Sox4 expression.
• The study found that Sox4 regulates melanoma cell migration and invasion in an NF-?B p50-dependent manner.

Sources:

• Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. The American Journal of Pathology, 177(6), 2741-52.
• Clinical Oncology Week, 2011.
• NewsRx.com, 2011.